Informed-money record
CADL · Candel Therapeutics, Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
1
Bearish filings
10
Named actors
10
Disclosed $ (bull / bear)
$3.0M / $611K
Recent disclosures
11 of 11 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-06-29 | Chief Scientific Officer Barone Francesca | sold | $236K | SEC ↗ |
| 2026-06-29 | Chief Technology Officer Tyagarajan Seshu | sold | $70K | SEC ↗ |
| 2026-06-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) FRANCESCA BARONE | filed notice to sell | $230K | SEC ↗ |
| 2026-06-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) SESHU P TYAGARAJAN | filed notice to sell | $69K | SEC ↗ |
| 2026-03-16 | Chief Medical Officer W. Garrett Nichols | adopted a selling plan | — | SEC ↗ |
| 2026-03-16 | Chief Scientific Officer Francesca Barone | adopted a selling plan | — | SEC ↗ |
| 2026-03-16 | Chief Technical and Development Director Seshu Tyagarajan | adopted a selling plan | — | SEC ↗ |
| 2026-03-13 | Chief Executive Officer, President and Director Paul Peter Tak | adopted a selling plan | — | SEC ↗ |
| 2026-03-13 | Chief Financial Officer, Treasurer and Secretary Charles Schoch | adopted a selling plan | — | SEC ↗ |
| 2026-02-23 | Director Manning Paul B | bought | $3.0M | SEC ↗ |
| 2025-07-28 | Chief Medical Officer Nichols William Garrett | sold | $7K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals